Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

BACKGROUND: Interferon and ribavirin have been used as therapeutic agents for chronic hepatitis C infection or C-compensated cirrhosis in the conventional treatment. Hepatitis C virus (HCV) -specific direct-acting antiviral agents that directly inhibit the growth process of HCV have been approved si...

Descripción completa

Detalles Bibliográficos
Autores principales: Omotani, Sachiko, Ishizaka, Toshihiko, Inoue, Miki, Nishida, Koji, Yasui, Yukako, Hatsuda, Yasutoshi, Mukai, Junji, Myotoku, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114806/
https://www.ncbi.nlm.nih.gov/pubmed/32266075
http://dx.doi.org/10.1186/s40780-020-00162-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114806/
https://www.ncbi.nlm.nih.gov/pubmed/32266075
http://dx.doi.org/10.1186/s40780-020-00162-y

Ejemplares similares